Nang Kwong Chemo-Pharmaceutical Co., Ltd.: Q1 2026 EPS 0.32 NTD
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Nang Kwong Chemo-Pharmaceutical Co., Ltd. (Stock Code: 1752) announced its Q1 2026 financial results, reporting an EPS of 0.32 NTD, operating revenue of 530 million NTD, and net profit of 32 million NTD, indicating steady performance in the biotechnology and medical sector.